Harms of FIT screening outweigh benefits for those with no history of fecal hemoglobin
Individuals with no detectable hemoglobin in previously negative fecal immunochemical tests had a “significantly higher” harm-to-benefit ratio for screening, with researchers suggesting less intensive screening for this population. “We recently examined the predictive power of [fecal hemoglobin (f-HB)] levels and showed that f-Hb levels measured on two consecutive negative FITs